Fentanyl patches: Preventable overdose

Prescrire International

Volumn 19, Issue 105, 2010, Pages 22-25

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 3A4; FENTANYL; FLUCONAZOLE; LOPINAVIR PLUS RITONAVIR; MORPHINE;

AGED; ANXIETY; APPETITE DISORDER; CHILD; CHRONIC PAIN; CLINICAL ARTICLE; COMA; CONFUSION; CONSTIPATION; DEPRESSION; DIZZINESS; DROWSINESS; DRUG DELIVERY SYSTEM; DRUG OVERDOSE; DRUG USE; EUPHORIA; EXERCISE; FATIGUE; FEMALE; FEVER; HALLUCINATION; HEADACHE; HEAT; HUMAN; HYPOTENSION; LUNG EDEMA; MEDICATION ERROR; NAUSEA; PRESCHOOL CHILD; RESPIRATION DEPRESSION; REVIEW; RHABDOMYOLYSIS; SEIZURE; SELF MEDICATION; SIDE EFFECT; VOMITING;

ADMINISTRATION, CUTANEOUS; ANALGESICS, OPIOID; CHRONIC DISEASE; FENTANYL; HUMANS; OVERDOSE; PAIN; PRODUCT SURVEILLANCE, POSTMARKETING; SKIN TEMPERATURE;

EID: 76549100817     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Prescrire Editorial Staff "Transdermal fentanyl patch" Prescrire lnt 1998; 7 (37): 138-140.
2. Prescrire Rédaction "fentanyl transdermique: les risques d'un opiacé" Rev Prescrire 2006; 26 (268): 26.
3. Prescrire Rédaction "fentanyl: attention I Dispositifs matriciels moins visibles" Rev Prescrire 2006; 26 (269): 107.
4. Prescrire Rédaction "fentanyl transdermique: un dosage faible bienvenu pour certaines situations" Rev Prescrire 2006; 26 (276): 660.
5. o". Douleurs non cancéreuses stables: une alternative à la morphine orale" Rev Prescrire 2008; 28 (302): 891.
6. Prescrire Rédaction "5-1 Patients traités par antalgique non spécifique" Rev Prescrire 2008; 28 (302 suppl. interactions médicamenteuses).
7. Centre de toxicologie de l'Institut national de santé publique du Québec "Les dangers des systèmes thérapeutiques transdermiques" Bulletin d'information toxicologique 2005; 21 (1): 1-13. www.inspq. qc.ca accessed 24 September 2008: 13 pages.
8. o". In French datasheet compendium: "Dictionnaire Vidal" Vidal, Issy-les-Moulineaux 2009: 696-698.
9. Pennsylvania Patient Safety Reporting System (PA-PSRS) "Fentanyl transdermal system: taking another look" PA-PSRS Patient safety advisory 2007; 4 (2): 1-8.
10. Santé Canada "Timbre transdermique de fentanyl et effets indésirables mortels" Bulletin canadien des effets indésirables 2008; 18 (3): 1-2.
11. o; November 2007: 11 pages.
12. Greenall J et al. "Safety issues with fentanyl patches require pharmaceutical care" CJHP 2008; 61 (1): 57-59.
13. Grenouillet-Delacre M et al. "Événements indésirables liés à l'usage du fentanyl délivré par dispositif transdermique" Rev Med Interne 2008; 29S: S65.
14. oee081020145 - observation détaillée" 8 May 2009: 3 pages.
15. o à couper ou pas? C'est selon l'avis des visiteurs médicaux" Rev Prescrire 2008; 28 (299): 711.
16. Gardner-Nix J "Caregiver toxidty from transdermal fentanyl" J Pain Symptom Manage 2001; 21 (6): 447-448.
17. Hardwick Jr WE et al. "Respiratory depression in a child unintentionally exposed to transdermal fentanyl patch" South Med J 1997; 90 (9): 962-964.
18. "Child dies from misuse of fentanyl patch" ISMP Medication Safety Alert! 2008; 13 (12): 1.
19. Meyer D and Tobias JD "Adverse effects following the inadvertent administration of opioids to infants and children" Clin Pediatr 2005; 44 (6): 499-503.
20. o07100101 du
21. February 2007" Bull Ordre Pharmaciens 2007; (397): 473-476.
22. Raymond B and Morawiecka I "Transdermal fentanyl (Duragesic): respiratory arrest in adolescents" Can Adv Reaction Newsletter 7004; 14 (4): 10 pages.
23. Teske J et al. "Fatal outcome in a child after ingestion of a transdermal fentanyl patch" Int J Legal Med 2007; 121 (2): 147-151.
24. van Rijswijk R and van Guidener C "A delirious patient with opioid intoxication after chewing a fentanyl patch" J Am Geriatr Soc 2006; 54 (8): 1298-1299.
25. Barrueto F et al. "The fentanyl tea bag" Vet Hum Toxicol 2004; 46 (1): 30-31.
26. Woodall KL et al. "Oral abuse of fentanyl patches (Duragesic): seven case reports" J Forensic Sci 2008; 53 (1): 222-225.
27. Arvanitis ML and Satonik RC "Transdermal fentanyl abuse and misuse" Am J Emerg Med 2002; 20 (1): 58-59.
28. Frölich M et al. "Opioid overdose in a patient using a fentanyl patch during treatment with a warming blanket" Anesth Analg 2001; 93 (3): 647-648.
29. Carter KA "Heat-assodated increase in transdermal fentanyl absorption" Am J Health Syst Pharm 2003; 60 (2): 191-192.
30. Newshan G "Heat-related toxidty with the fentanyl transdermal patch" J Pain Symptom Man- age 1998; 16 (5): 277-278.
31. "New fentanyl warnings: more needed to protect patients" ISMP Medication Safety Alert! 2005; 10 (16): 1-3.
32. Hallberg P et al. "Possible fluconazole-fentanyl interaction-a case report" Eur J Clin Pharmacol 2006; 62 (6): 491-492.
33. U.S. Food and Drug Administration "Information for Healthcare professionals. Fentanyl transdermal system" 21 December 2007. www. fda.gov accessed 24 December 2007: 3 pages.
34. Prescrire Editorial Staff "Fentanyl iontophoretic transdermal system" Prescrire Int 2008; 17 (96): 146-149.
35. Prescrire Editorial Staff "Fentanyl transdermal system: market withdrawal" Prescrire Int 2009; 18 (101): 110.
36. Commission des communautés européennes "Dé cision de la commission suspendant l'autori-sation de mise sur le marché du médicament Ion-sys-fentanyl" 16 January 2009: 2 pages.
37. Siranyan V and Locher F "L'obligation d'information et de conseil du pharmacien" Bull Ordre Pharmaciens 2008; (399): 197-203.
38. Prescrire Rédaction "Fiche 1. Le cytochrome P450 en bref" Rev Prescrire 2008; 28 (302 suppl. interactions médicamenteuses).